Relationship between change in skin score and disease outcome in diffuse cutaneous systemic sclerosis: Application of a latent linear trajectory model
about
Recent advances in the genetics of systemic sclerosis: toward biological and clinical significanceMolecular subsets in the gene expression signatures of scleroderma skin.Emerging targets for the treatment of scleroderma.Pathogenesis of Systemic Sclerosis.A multicenter, randomized, double-blind, placebo-controlled trial of oral type I collagen treatment in patients with diffuse cutaneous systemic sclerosis: I. oral type I collagen does not improve skin in all patients, but may improve skin in late-phResponse of T-cell subpopulations to superantigen and recall antigen stimulation in systemic sclerosis.Clinical trials in systemic sclerosis: lessons learned and outcomes.Editorial: Scleroderma: Bringing a Disease From Black-and-White Into TechnicolorSystemic sclerosis: an update for clinicians.Skin involvement in systemic sclerosis.Course of the modified Rodnan skin thickness score in systemic sclerosis clinical trials: analysis of three large multicenter, double-blind, randomized controlled trials.Skin thickness progression rate: a predictor of mortality and early internal organ involvement in diffuse sclerodermaTreatment of diffuse systemic sclerosis with hyperimmune caprine serum (AIMSPRO): a phase II double-blind placebo-controlled trial.Recognizing systemic sclerosis: comparative analysis of various sets of classification criteria.Rheumatic manifestations of skin disease.Association of anti-RNA polymerase III autoantibodies and cancer in scleroderma.Biomarkers in systemic sclerosis.Evidence-based management of rapidly progressing systemic sclerosis.Registries in systemic sclerosis: a worldwide experience.Capturing the heterogeneity in systemic sclerosis with genome-wide expression profiling.Scleroderma therapy: clinical overview of current trends and future perspective.Targeted therapies for systemic sclerosis.Personalized medicine in systemic sclerosis: facts and promises.Cytokines in the immunopathology of systemic sclerosis.Risk factors for severity and manifestations in systemic sclerosis and prediction of disease course.Strategy for treatment of fibrosis in systemic sclerosis: Present and future.The association between systemic sclerosis disease manifestations and esophageal high-resolution manometry parameters.Biomarkers in Scleroderma: Progressing from Association to Clinical Utility.Dermal mast cell density in fingers reflects severity of skin sclerosis in systemic sclerosis.Changes in forced vital capacity over time in systemic sclerosis: application of group-based trajectory modelling.Sphingosine-1-Phosphate Receptor 5 Modulates Early-Stage Processes during Fibrogenesis in a Mouse Model of Systemic Sclerosis: A Pilot Study.Cost-of-illness of patients with systemic sclerosis in a tertiary care centre.Prediction of worsening of skin fibrosis in patients with diffuse cutaneous systemic sclerosis using the EUSTAR database.Scleroderma keratinocytes promote fibroblast activation independent of transforming growth factor beta.Assessment of skin involvement in systemic sclerosis.Factors influencing early referral, early diagnosis and management in patients with diffuse cutaneous systemic sclerosis.Predictive value of European Scleroderma Group Activity Index in an early scleroderma cohort.Novel classification for global gene signature model for predicting severity of systemic sclerosis.A Paradigmatic Interplay between Human Cytomegalovirus and Host Immune System: Possible Involvement of Viral Antigen-Driven CD8+ T Cell Responses in Systemic Sclerosis
P2860
Q28088499-3EACFACB-E554-4C08-9431-61B99D8E1EE6Q33354088-62D96397-7EDD-445B-AD55-10F7000046EEQ34270856-39DE5DCB-B047-4095-9081-39B0B6C1511AQ35693212-97782512-2929-46CA-AF3B-365CD4220A8BQ35878705-18E849F0-07B3-4E07-831A-319580AF87BFQ36021130-9D006BC4-EEC2-43B1-A132-7AD30271559CQ36130965-709A18B3-0F4F-49A0-ABA7-71FEDE67BBDFQ36591571-CA9BF304-3676-4F4B-8ED3-A9277E29DD4BQ37265423-CB20C639-4A83-4078-92C6-0066A6F4B134Q37265837-FA95CC3A-E2CE-4CFD-93B9-1D70549CB340Q37301159-4DCBE067-52B6-473F-8838-C5CC7F436E16Q37434973-F04921B3-038A-4109-9D92-216E49229CE5Q37465397-D2CEBD82-6E64-46B5-AC33-7D78494196C8Q37590671-BE25F229-117B-4EED-8A0C-4EEF174BDCC1Q37620086-B85E83E0-5D1E-432D-BF52-B4B468414870Q37690735-C3A030A5-3DBA-4F9C-AEC3-C5F523BEA585Q37730018-235D2D3B-2583-433A-A664-995BCCC821C2Q37763779-C2F99634-03BB-4D48-A0AD-FBFDCAA8D2EDQ37819494-2EDB81F1-41C8-4855-AE26-BD38333FCFA6Q37905787-EA7E133A-4E29-41A9-8CFC-98CC410AE4E3Q38046467-FCA2E9B0-A65F-4373-BEAF-4B5AA21276F7Q38097276-3A62B349-5032-4A4A-A8BB-8595BE11D2F9Q38206152-910740FB-29DC-4F4D-A368-17390C0FC08EQ38543692-D6EF8A7B-A9E4-47E1-805A-38B727419114Q38630663-F7B11849-A208-4D88-AED3-53E6A9481999Q38701990-88E1D031-DD7C-40ED-973A-16919B6FB2BAQ38752477-79A6C616-5FC6-441A-B9A2-2AD3E0EDCB35Q38771824-9FC05E13-6CCA-4D4D-8DB2-061FDA537ACAQ40082697-D2FC66B9-C5DA-43FB-804D-C2FAB63F85DFQ41199736-BE2E9AB9-5E01-4705-8BDA-5DDAD9DC6391Q42369819-1386DE96-1067-40A2-ACBD-7FD8780D87D7Q45025423-E06E70A4-2AD1-4407-9CF2-3E64F1205F50Q46274957-B18820BE-0926-4ADA-BCF3-5B69793CCB8BQ47610065-49BEDF0B-144D-4422-8C79-96CB3CA5AC98Q47835767-91DE636C-E283-4A4F-8D23-E29874360380Q50132702-C3A29459-7560-49FA-8322-18C19EE03C49Q53402736-9C112DAD-E6E1-4A75-9E9D-C442EBF5C6DFQ55490826-97B50522-C756-4F98-A29F-015A0001765AQ58723092-2B467271-FC17-4536-8786-65299C66256F
P2860
Relationship between change in skin score and disease outcome in diffuse cutaneous systemic sclerosis: Application of a latent linear trajectory model
description
article
@en
wetenschappelijk artikel
@nl
наукова стаття, опублікована у 2007
@uk
name
Relationship between change in ...... latent linear trajectory model
@en
Relationship between change in ...... latent linear trajectory model
@nl
type
label
Relationship between change in ...... latent linear trajectory model
@en
Relationship between change in ...... latent linear trajectory model
@nl
prefLabel
Relationship between change in ...... latent linear trajectory model
@en
Relationship between change in ...... latent linear trajectory model
@nl
P2093
P356
P1476
Relationship between change in ...... latent linear trajectory model
@en
P2093
Carol M. Black
Christopher P. Denton
Lynne Shand
Mansour Hoseini
Svetlana Nihtyanova
P304
P356
10.1002/ART.22721
P577
2007-01-01T00:00:00Z